Passage Bio announces 1-for-20 reverse stock split effective July 14

Go back to Passage Bio announces 1-for-20 reverse stock split effective July 14

Passage Bio Announces 1-for-20 Reverse Stock Split

July 10, 2025 7:00 AM UTC

PHILADELPHIA, July 10, 2025 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Passage Bio or the Company) (NASDAQ: PASG), a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases, today announced that its Board of Directors (Board) has approved a reverse stock split of the companys outstanding shares of common stock at a ratio of 1-for-20. The reverse stock split will become effective at 12:01 a.m. Eastern time on July 14, 2025. Passage Bios common stock will begin trading on a post-reverse stock split basis on July 14, 2025, under the... More